{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "red blood cells count decreased"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1, grade 2, grade 3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "GGT increase"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['33']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "oral mucositis"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dyspepsia"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 4 (67)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 1, grade 3]",
                "outcomes": "[3 (50), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (33), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "myalgia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "1",
                    "dose": "<100 mg",
                    "n": "6",
                    "adverse_event": "LVEF decrease"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "red blood cells count decreased"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "red blood cells count decreased"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "red blood cells count decreased"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "red blood cells count decreased"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "red blood cells count decreased"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "red blood cells count decreased"
                },
                "measures": "[grade 1]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "leukopenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "neutropenia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "AST increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[4 (100)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "ALT increase"
                },
                "measures": "[grade 1]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hypocalcemia"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "hyponatremia"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "nausea"
                },
                "measures": "[grade 2, grade 3]",
                "outcomes": "[2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "vomiting"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "diarrhea"
                },
                "measures": "[grade 1, grade 2]",
                "outcomes": "[1 (25), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "abdominal pain"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "dysgeusia"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "anorexia"
                },
                "measures": "[grade 2]",
                "outcomes": "[2 (50)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "alopecia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "fatigue"
                },
                "measures": "[grade 2]",
                "outcomes": "[3 (75)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pneumonitis"
                },
                "measures": "[grade 3]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "peripheral sensory neuropathy"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "arthralgia"
                },
                "measures": "[grade 1]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "drug": "dasatinib",
                    "dose_level": "2",
                    "dose": "100 mg",
                    "n": "4",
                    "adverse_event": "pericardial effusion"
                },
                "measures": "[grade 2]",
                "outcomes": "[1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 41,
    "total_ground_truth_claims": 126,
    "number_of_matches": 20
}